pubmed-article:10397094 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10397094 | lifeskim:mentions | umls-concept:C0011923 | lld:lifeskim |
pubmed-article:10397094 | lifeskim:mentions | umls-concept:C0001624 | lld:lifeskim |
pubmed-article:10397094 | lifeskim:mentions | umls-concept:C0205282 | lld:lifeskim |
pubmed-article:10397094 | lifeskim:mentions | umls-concept:C0221198 | lld:lifeskim |
pubmed-article:10397094 | lifeskim:mentions | umls-concept:C0205183 | lld:lifeskim |
pubmed-article:10397094 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:10397094 | lifeskim:mentions | umls-concept:C0872169 | lld:lifeskim |
pubmed-article:10397094 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:10397094 | pubmed:dateCreated | 1999-7-28 | lld:pubmed |
pubmed-article:10397094 | pubmed:abstractText | OBJECTIVE: The aim of this study was to differentiate benign from malignant adrenal tumors using positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) in patients with unilateral adrenal masses originally detected by CT or MR imaging. CONCLUSION: PET imaging with FDG can metabolically characterize adrenal masses. Abnormally increased FDG uptake in adrenal malignancies allows one to differentiate these abnormalities from benign lesions. Whole-body PET can also reveal extraadrenal tumor sites in patients with malignant tumors, using a single imaging technique for accurate disease staging. | lld:pubmed |
pubmed-article:10397094 | pubmed:language | eng | lld:pubmed |
pubmed-article:10397094 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10397094 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:10397094 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10397094 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10397094 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10397094 | pubmed:month | Jul | lld:pubmed |
pubmed-article:10397094 | pubmed:issn | 0361-803X | lld:pubmed |
pubmed-article:10397094 | pubmed:author | pubmed-author:AlfaniDD | lld:pubmed |
pubmed-article:10397094 | pubmed:author | pubmed-author:ZivielloMM | lld:pubmed |
pubmed-article:10397094 | pubmed:author | pubmed-author:SalvatoreMM | lld:pubmed |
pubmed-article:10397094 | pubmed:author | pubmed-author:BazzicalupoLL | lld:pubmed |
pubmed-article:10397094 | pubmed:author | pubmed-author:MaurelFF | lld:pubmed |
pubmed-article:10397094 | pubmed:author | pubmed-author:MainolfiCC | lld:pubmed |
pubmed-article:10397094 | pubmed:author | pubmed-author:PanicoM RMR | lld:pubmed |
pubmed-article:10397094 | pubmed:author | pubmed-author:ImparatoCC | lld:pubmed |
pubmed-article:10397094 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10397094 | pubmed:volume | 173 | lld:pubmed |
pubmed-article:10397094 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10397094 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10397094 | pubmed:pagination | 25-9 | lld:pubmed |
pubmed-article:10397094 | pubmed:dateRevised | 2008-2-15 | lld:pubmed |
pubmed-article:10397094 | pubmed:meshHeading | pubmed-meshheading:10397094... | lld:pubmed |
pubmed-article:10397094 | pubmed:meshHeading | pubmed-meshheading:10397094... | lld:pubmed |
pubmed-article:10397094 | pubmed:meshHeading | pubmed-meshheading:10397094... | lld:pubmed |
pubmed-article:10397094 | pubmed:meshHeading | pubmed-meshheading:10397094... | lld:pubmed |
pubmed-article:10397094 | pubmed:meshHeading | pubmed-meshheading:10397094... | lld:pubmed |
pubmed-article:10397094 | pubmed:meshHeading | pubmed-meshheading:10397094... | lld:pubmed |
pubmed-article:10397094 | pubmed:meshHeading | pubmed-meshheading:10397094... | lld:pubmed |
pubmed-article:10397094 | pubmed:meshHeading | pubmed-meshheading:10397094... | lld:pubmed |
pubmed-article:10397094 | pubmed:meshHeading | pubmed-meshheading:10397094... | lld:pubmed |
pubmed-article:10397094 | pubmed:meshHeading | pubmed-meshheading:10397094... | lld:pubmed |
pubmed-article:10397094 | pubmed:meshHeading | pubmed-meshheading:10397094... | lld:pubmed |
pubmed-article:10397094 | pubmed:meshHeading | pubmed-meshheading:10397094... | lld:pubmed |
pubmed-article:10397094 | pubmed:meshHeading | pubmed-meshheading:10397094... | lld:pubmed |
pubmed-article:10397094 | pubmed:meshHeading | pubmed-meshheading:10397094... | lld:pubmed |
pubmed-article:10397094 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10397094 | pubmed:articleTitle | Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions. | lld:pubmed |
pubmed-article:10397094 | pubmed:affiliation | Medicina Nucleare e Radiodiagnostica, Istituto Nazionale dei Tumori, Naples, Italy. | lld:pubmed |
pubmed-article:10397094 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10397094 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:10397094 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10397094 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10397094 | lld:pubmed |